Items tagged with Guidelines
ARLINGTON, Va., December 8 – Patients at risk for latent or active tuberculosis (TB) infection should be assessed with newer tests, including interferon-gamma release assays (IGRAs) and molecular diagnostics, recommend guidelines on TB diagnosis developed by the American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA) and Centers for Disease Control and Prevention (CDC) and published in the journal Clinical Infectious Diseases. Advances in testing prompted the first new guidelines on TB diagnosis in 17 years.
Although pediatric tuberculosis (TB) remains relatively uncommon in Canada, some populations -- including Aboriginal communities -- have a much higher burden of disease. As a result, Canada should focus on addressing the high rates of the disease in these communities, according to a review in CMAJ (Canadian Medical Association Journal), http://www.cmaj.ca/site/press/cmaj.151212.pdf.
BEIJING, Feb. 16 (Xinhua) -- China's central government has issued a guideline on the prevention and treatment of tuberculosis.
The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) issued a Bedaquiline Bulletin.
A groundbreaking guide aimed at helping people to set up community-based HIV prevention services has been launched in Cape Town.
Human rights violations continue to be a barrier to accessing TB prevention, diagnosis and treatment services for many marginalized groups such as prisoners, miners and immigrants. The Stop TB Partnership collaborated with UNDP to develop the Guide, which will help civil society and government to address legal and policy barriers and opportunities to increase access to TB health services.
WHO to review its interim guidance on the use of delamanid in the treatment of multidrug-resistant TB following the release of Phase III clinical trial results (post)
The World Health Organization (WHO) has started preparations for a rapid review of its interim guidance on the use of delamanid in the treatment of patients with multidrug-resistant tuberculosis (MDR-TB). This follows the release of the phase III randomised control trial results by Otsuka Pharmaceutical at the 48th Union World Conference on Lung Health on 13 October.
12 December 2017 - Today on Universal Health Coverage Day, The International Union Against Tuberculosis and Lung Disease (The Union) and the International Council of Nurses (ICN) have launched updated guidance for health care workers who are involved in detecting and caring for patients with tuberculosis (TB).
WHO and USAID release guide to support countries in developing national action plans on public-private mix for TB prevention and care (post)
23 February, Geneva - The World Health Organization and the United States Agency for International Development (USAID) have released a new guide to help countries strategically and systematically scale-up the engagement of all care providers in TB prevention and care. The Guide to develop a national action plan on Public-Private Mix (PPM) – is a planning document designed to facilitate the integration of strong public-private mix (PPM) components into national TB strategic plans that are the basis for Global Fund proposals and national budgeting processes.
The World Health Organization (WHO) Global TB Programme convened a webinar on the WHO guideline development process, with a focus on guidelines for the management of multidrug-resistant TB (MDR-TB). The webinar was held on 27 February 2018, based on a request from civil society participants at a WHO meeting in January 2018 to discuss the process, format, and dissemination of WHO guidelines. The webinar was attended by more than 60 participants. Tereza Kasaeva, Director of the WHO Global TB Programme, opened the event and welcomed participants. The webinar was moderated by Haileyesus Getahun, Coordinator of TB/HIV and Community Engagement, Global TB Programme.
Page 2 of 6 · Total posts: 0←First 1 2 3 Last→